Cargando…
Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity
Tuberculosis (TB) caused by Mycobacterium tuberculosis infection is responsible for the most deaths by a single infectious agent worldwide, with 1.6 million deaths in 2017 alone. The World Health Organization, through its “End TB” strategy, aims to reduce TB deaths by 95% by 2035. In order to reach...
Autores principales: | Stewart, Erica, Triccas, James A, Petrovsky, Nikolai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724148/ https://www.ncbi.nlm.nih.gov/pubmed/31409028 http://dx.doi.org/10.3390/microorganisms7080255 |
Ejemplares similares
-
Correction: Stewart et al. Adjuvant Strategies for More Effective Tuberculosis Vaccine Immunity. Microorganisms 2019, 7, 255
por: Stewart, Erica, et al.
Publicado: (2022) -
Intrapulmonary vaccination with delta-inulin adjuvant stimulates non-polarised chemotactic signalling and diverse cellular interaction
por: Ferrell, Kia C., et al.
Publicado: (2021) -
Delta inulin-based adjuvants promote the generation of polyfunctional CD4(+) T cell responses and protection against Mycobacterium tuberculosis infection
por: Counoupas, Claudio, et al.
Publicado: (2017) -
Neonatal vaccine effectiveness and the role of adjuvants
por: Sakala, Isaac G., et al.
Publicado: (2019) -
Comparative Safety of Vaccine Adjuvants: A Summary of Current Evidence and Future Needs
por: Petrovsky, Nikolai
Publicado: (2015)